ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Comments on Proposed Medicare Advantage Changes

From the College  |  February 10, 2025

In response to proposed changes to the Medicare Advantage and prescription drug programs for contract year 2026, the ACR submitted comments on the provisions related to the Inflation Reduction Act, prior authorization and the influence that pharmacy benefit managers have on the placement of biosimilars on formularies.

The HHS Seeks Comments on Proposed Changes to HIPAA Security Rule

From the College  |  February 10, 2025

The proposed changes aim to address modern breach and cybersecurity risks to electronic protected health information and common deficiencies observed by the HHS in Security Rule compliance investigations.

The ACR Commends Legislation to Address Harmful Medicare Payment Cuts to Physicians

From the College  |  February 5, 2025

The Medicare Patient Access and Practice Stabilization Act of 2025 would fully offset the harmful 2.8% cut in the MPFS and include an additional 2% payment update to physician services furnished after April 1.

Answering the Call: Anisha Dua, MD, MPH, Looks Ahead to New Role on Committee on Training

Carina Stanton  |  January 29, 2025

Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.

Skin disorder, pepper appearance from scleroderma, autoimmune disease male hand Skin disorder pepper appearance from vitiligo,scleroderma raynaud, medical concept autoimmune disease. Credit: Adobe Stock | Trsakaoe

Through Thick & Thin: Updates in Scleroderma

Jason Liebowitz, MD, FACR  |  January 22, 2025

Pulmonary hypertension and Raynaud’s phenomenon are just some of the symptoms patients with systemic sclerosis (SSc) may experience. Here are insights into the diagnosis and management of SSc.

Can MRI Predict Osteoarthritis’ Progression?

Arthritis & Rheumatology  |  January 22, 2025

In individuals without radiographic knee osteoarthritis (OA), Chang et al. investigated whether magnetic resonance imaging (MRI) defined knee OA at baseline was associated with incident radiographic and symptomatic disease during up to 11 years of follow-up. The researchers found the two current MRI definitions of knee OA may not adequately predict the development of radiographic and symptomatic disease.

Small Postcard, Big Impact: ACR’s New Grassroots Group Empowers Members to Be Rheumatology Advocates

From the College  |  January 20, 2025

Helping ACR/ARP members talk to lawmakers about rheumatology-related policy is a key part of the ACR’s advocacy efforts. A postcard-writing campaign to Congress highlights outreach efforts of a new member engagement working group.

Rheumatology 2025 State Legislative Preview

Joseph Cantrell, JD  |  January 20, 2025

As state legislatures begin to convene their sessions in 2025, several key issues related to rheumatology are expected to take center stage, including drug costs, utilization management, telehealth and copay accumulators.

2024 Federal Legislative Recap

From the College  |  January 20, 2025

Although many rheumatology priorities were cut from big funding bills in the 118th Congress, some policy victories and signals of progress set the stage for the new year

Answering the Call: Anisha Dua, MD, MPH, Looks Ahead to New Role as Committee on Training Chair

Carina Stanton  |  January 16, 2025

Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 332
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences